within Pharmacolibrary.Drugs.ATC.J;

model J01AA04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.94,
    Cl             = 0.0005,
    adminDuration  = 600,
    adminMass      = 300 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01AA04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Lymecycline is a broad-spectrum tetracycline antibiotic used in the treatment of various infections, such as acne vulgaris and respiratory tract infections. It is a semisynthetic derivative of tetracycline and is approved for use in several countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are based on healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Schreiner, A, &amp; Digranes, A (1985). Pharmacokinetics of lymecycline and doxycycline in serum and suction blister fluid. <i>Chemotherapy</i> 31(4) 261–265. DOI:<a href=&quot;https://doi.org/10.1159/000238345&quot;>10.1159/000238345</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/4028871/&quot;>https://pubmed.ncbi.nlm.nih.gov/4028871</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01AA04;
